NCT01293279View on ClinicalTrials.gov

HCV (Hepatitis C Virus) Viral and Host Genotyping (IL28B, Interleukin 28B) in China

CompletedOBSERVATIONAL

Enrollment

997

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions

Hepatitis C

Trial Locations (1)

100044

Lai Wei, Beijing

Sponsors

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Peking University People's Hospital

OTHER